Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS (NCT06810219)
Cognixion ALS BCI Longitudinal Study
🩺 Plain-English Summary (8th-Grade Level)
The goal of this study is refine the usability of a BCI based communication platform. The study will take place in the greater Los Angeles area and will enroll up to 10 participants with late stage ALS. Each subject will receive a Cognixion Axon-R augmented reality brain computer interface and associated communication software. The study duration is 3 months for each participant. The key questions that will be addressed in this study are: 1. How quickly can participants learn and gain confidence with a pure BCI interface. 2. How effective are alternate input modalities including eye tracking for this use case. 3. Identify the extent to which generative AI based personalization impacts the communication quality. Key measures include: ITR - information transfer rate SUS - system usability scale
Who can join: Review the eligibility criteria below.
Location: Cognixion — Santa Barbara, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Cognixion — Santa Barbara, California
📞 Contact the Study Coordinator
Phone: (805) 320-0774
Email: chris@cognixion.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in ALS (Amyotrophic Lateral Sclerosis)
- T-regulatory Cells in ALS — Boston, Massachusetts
- Augmented Reality BCI Longitudinal Study for Persons With ALS, Stroke, TBI and SCI Utilizing Cognixion + Apple Vision Pro — Santa Barbara, California
- Tofersen in Non-SOD1 ALS — Atlanta, Georgia
- A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis — Leuven,
- Tongue-strengthening Exercises in People With ALS. — Davie, Florida
Explore by condition: All ALS (Amyotrophic Lateral Sclerosis) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.